Serum ferritin threshold of less than or equal to 20ng/mL is suggested for children ages 9 months to 4 years. HealthDay News — In guidelines issued by the American Society of Hematology and published ...
The approval makes remibrutinib the first targeted therapy approved for symptomatic dermographism, expanding its indication beyond chronic spontaneous urticaria.
The novel GPR6 inhibitor met its primary endpoint in the phase 3 ARISE trial, achieving a statistically significant reduction in daily OFF time and demonstrating non-dopaminergic motor and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results